Cargando…
Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations
BACKGROUND: Refractory blood loss is a common problem in surgeries for acute type A aortic dissections. Significant evidence has supported the benefit of using recombinant activated factor VII (rFVIIa) to control of intractable bleeding in patients after cardiac surgery. In this prospective clinical...
Autores principales: | Yan, Wen, Xuan, Chengluan, Ma, Guojia, Zhang, Liang, Dong, Ning, Wang, Zijian, Xu, Rihao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156631/ https://www.ncbi.nlm.nih.gov/pubmed/25179738 http://dx.doi.org/10.1186/s13019-014-0156-y |
Ejemplares similares
-
Successful Hemostasis with Recombinant Activated Factor VII in a Patient with Massive Hepatic Subcapsular Hematoma
por: Lee, Ju-Hee, et al.
Publicado: (2009) -
Successful hemostasis in refractory alveolar hemorrhage using low-dose recombinant activated factor VII
por: Selickman, John, et al.
Publicado: (2022) -
Surgical approach for the treatment of aortoesophageal fistula combined with dual aortic aneurysms: a case report
por: Xu, Rihao, et al.
Publicado: (2013) -
Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis
por: Altman, Raul, et al.
Publicado: (2006) -
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency
por: Seita, Ikuo, et al.
Publicado: (2023)